RADL3 ESG and Integrity Program from the FRE

Raia Drogasil / RD Saúde (RADL3) FRE ESG section shows how a Brazilian pharmacy retailer documents framework-aligned reporting and a formal Integrity Program — including an explicit three-year claim of no confirmed corruption/fraud cases against the public administration.

This page summarizes an ESG/compliance analysis from the 2025 FRE. apicvm returns the filings.

The research question

> What ESG practices and integrity-program evidence does the FRE disclose?

ESG disclosure

Element Disclosure
Annual & Sustainability Report Since 2016
Frameworks GRI (2021), IIRC, TCFD, SASB (pharmacy retail)
Assurance DNV limited assurance on 2024 non-financial info
Materiality Updated 2024; pillars People / Business / Planet / Transversal
GHG inventory Scopes 1, 2, and 3 with detailed categories

Integrity program evidence

  1. Código da Gente — Board-approved 30 Apr 2019, updated 27 Sep 2021, plus Anti-Corruption, Channel, and Conflict policies.
  2. Program pillars — tone at the top, risk profiling, code/policies, training, Ethics Conversation channel, non-retaliation, governance.
  3. Org design — Compliance under Legal; Ethics Affairs Commission (7 directors, weekly for sensitive cases); Ethics Committee (Legal + CEO, semi-annual); Audit Committee / Board reporting.
  4. Channel — third-party Conversa Ética, 24/7, anonymous, special flows for senior-leadership allegations.
  5. Training — RD University mandatory on hire/promotion; supplier Code of Conduct.
  6. Monitoring — internal audit risk reviews; annual related-party self-declaration mapping.

Operational claim to verify in-source

The FRE states no confirmed reports of diversion, corruption, fraud, or illicit acts against the public administration in the last three fiscal years. Treat that as a company assertion in the filing — not an independent audit conclusion beyond the assurance scope described.

Why section routing helps

name=ASG (or Integrity/Compliance titles) keeps channel governance and assurance language together for compliance research agents.

Replicate with apicvm

export APICVM_KEY='apicvm_...'
export APICVM_URL='https://apicvm.dev'

curl -H "Authorization: Bearer $APICVM_KEY" \
  "$APICVM_URL/v1/companies/resolve?query=RADL3&by=ticker"

curl -H "Authorization: Bearer $APICVM_KEY" \
  "$APICVM_URL/v1/documents?ticker=RADL3&type=FRE&year=2025&name=ASG"

curl -X POST -H "Authorization: Bearer $APICVM_KEY" \
  -H "Content-Type: application/json" \
  -d '{"callback_url":"https://your-server/callback","document":{"id":"<id>"}}' \
  "$APICVM_URL/v1/document-text-extractions"

Methodology note

Findings above come from a completed Hold analysis of the company's public 2025 FRE. This is a research illustration, not investment, legal, or tax advice. Verify numbers against the original filing before trading, modeling, or publishing reports.

Limitations

  • apicvm returns filings and extracted text — it does not classify risks or compute coverage ratios.
  • Figures are as of the FRE filing date; later ITRs or facts relevantes can update them.
  • Corpus coverage depends on ingestion lag.

Next steps

Ready to integrate?

Get an API key and start querying Brazilian CVM filings programmatically.